Chapman James H, Ghosh Debolina, Attari Seyyedmorteza, Ude Chinedu C, Laurencin Cato T
The Cato T. Laurencin Institute for Regenerative Engineering, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030-3711, USA.
Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences, UConn Health, Farmington, CT 06030, USA.
Regen Eng Transl Med. 2024 Jun;10(2):127-146. doi: 10.1007/s40883-023-00309-x. Epub 2023 Jun 27.
Osteoarthritis (OA) is a global musculoskeletal disorder that affects primarily the knee and hip joints without any FDA-approved disease-modifying therapies. Animal models are essential research tools in developing therapies for OA; many animal studies have provided data for the initiation of human clinical trials. Despite this, there is still a need for strategies to recapitulate the human experience using animal models to better develop treatments and understand pathogenesis. Since our last review on animal models of osteoarthritis in 2016, there have been exciting updates in OA research and models. The main purpose of this review is to update the latest animal models and key features of studies in OA research.
We used our existing classification method and screened articles in PubMed and bibliographic search for animal OA models between 2016 and 2023. Relevant and high-cited articles were chosen for inclusion in this narrative review.
Recent studies were analyzed and classified. We also identified ex vivo models as an area of ongoing research. Each animal model offers its own benefit in the study of OA and there are a full range of outcome measures that can be assessed. Despite the vast number of models, each has its drawbacks that have limited translating approved therapies for human use.
Depending on the outcome measures and objective of the study, researchers should pick the best model for their work. There have been several exciting studies since 2016 that have taken advantage of regenerative engineering techniques to develop therapies and better understand OA.
Osteoarthritis (OA) is a chronic debilitating disease without any cure that affects mostly the knee and hip joints and often results in surgical joint replacement. Cartilage protects the joint from mechanical forces and degrades with age or in response to injury. The many contributing causes of OA are still being investigated, and animals are used for preclinical research and to test potential new treatments. A single consensus OA animal model for preclinical studies is non-existent. In this article, we review the many animal models for OA and provide a much-needed update on studies and model development since 2016.
骨关节炎(OA)是一种全球性的肌肉骨骼疾病,主要影响膝关节和髋关节,目前尚无任何获得美国食品药品监督管理局(FDA)批准的改善病情的疗法。动物模型是开发骨关节炎治疗方法的重要研究工具;许多动物研究为启动人类临床试验提供了数据。尽管如此,仍需要一些策略来利用动物模型重现人类的病情,以便更好地开发治疗方法并了解发病机制。自我们上次在2016年对骨关节炎动物模型进行综述以来,骨关节炎的研究和模型有了令人兴奋的进展。本综述的主要目的是更新骨关节炎研究中最新的动物模型及研究的关键特征。
我们采用现有的分类方法,在PubMed数据库中筛选文章,并通过文献检索查找2016年至2023年间的动物骨关节炎模型。选择相关且被高引用的文章纳入本叙述性综述。
对近期的研究进行了分析和分类。我们还将体外模型确定为一个正在进行研究的领域。每种动物模型在骨关节炎研究中都有其自身的优势,并且有一系列可以评估的结果指标。尽管有大量的模型,但每种模型都有其缺点,这限制了将已批准的疗法转化为人类应用。
根据研究的结果指标和目标,研究人员应选择最适合其工作的模型。自2016年以来,有几项令人兴奋的研究利用再生工程技术来开发治疗方法并更好地了解骨关节炎。
骨关节炎(OA)是一种无法治愈的慢性致残性疾病,主要影响膝关节和髋关节,常导致手术关节置换。软骨可保护关节免受机械力的影响,并会随着年龄增长或因受伤而退化。骨关节炎的许多致病原因仍在研究中,动物被用于临床前研究和测试潜在的新治疗方法。目前不存在用于临床前研究的单一公认的骨关节炎动物模型。在本文中,我们综述了多种骨关节炎动物模型,并提供了自2016年以来对研究和模型开发的急需更新。